-
Mashup Score: 1
Stephen Liu, MD, discusses the recent announcement that the phase 3 MARIPOSA trial met its final pre-specified secondary endpoint of overall survival in non-small cell lung cancer.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Following Allogeneic HCT, Dietary Fiber Intake Improves Overall Survival and GVHD Mortality | Cancer Nursing Today - 5 hour(s) ago
The study found that increased fiber intake was associated with better OS in patients who underwent allogeneic HCT, especially among patients who ate a high fiber diet.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet-
š° Research presented at #ASH24 by a team from @cityofhope may "suggest that dietary fiber could be used in the prevention of GVHD." ā”ļø Learn more about the findings and implications: https://t.co/I5AYXB57ZI #bmtsm #GVHD #ASH2024 https://t.co/TsSDB3TsIV
-
-
Mashup Score: 1The green Mediterranean diet that slows down ageing - 6 hour(s) ago
Join Sam in the comments section and have your nutrition-related questions answered.
Source: www.yahoo.comCategories: General Medicine News, Partners & KOLsTweet-
The green Mediterranean diet that slows down ageing https://t.co/ebrobHaUUY via @@Yahoo
-
-
Mashup Score: 2Dr. Banerjee Describes Practice-Changing MM Data Presented at ASH 2024 | Blood Cancers Today - 6 hour(s) ago
Rahul Banerjee, MD, of the Fred Hutchinson Cancer Center, discusses notable studies in myeloma presented at ASH 2024.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
ā @RahulBanerjeeMD, of @fredhutch, discussed notable studies in multiple #myeloma from #ASH24, including the AQUILA study of daratumumab in high-risk smoldering MM and the CARTITUDE-4 trial of cilta-cel in lenalidomide-refractory MM. ā”ļø Watch here! https://t.co/oj947MOOl5 https://t.co/T0saPGGrlt
-
-
Mashup Score: 0From Misconceptions to Understanding - 6 hour(s) ago
How Maasai men in Kenya champion family planning and maternal health care for healthier communities
Source: medium.comCategories: General Medicine News, Partners & KOLsTweet-
#MaleEngagement in womenās health can save lives. Read the story of how USAID is working with men in Kenya to champion #ReproHealth and family planning: https://t.co/ZHdV51k9ui
-
-
Mashup Score: 0Swapping Bacon for Nuts May Lower Dementia Risk by 20 Percent, New Study Finds | VegNews - 6 hour(s) ago
Recent research has identified a significant link between the consumption of processed red meats and an increased risk of dementia.
Source: VegNews.comCategories: General Medicine News, Partners & KOLsTweet-
Swapping Bacon for Nuts May Lower Dementia Risk by 20 Percent, New Study Finds - https://t.co/5zIXtn1Dzd
-
-
Mashup Score: 1Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study - 6 hour(s) ago
Key Points. D-R maintenance improved MRD-negative conversion rate in NDMM patients who were MRD positive post-transplant, versus R maintenance.PFS favored
Source: ashpublications.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @bdermanmd: And it is published! https://t.co/QBRxpvemIu
-
-
Mashup Score: 2
Myeloma Paper of the Day, January 15th, suggested by Robert Orlowski / ASCT, cancer, Jana Schlenzka, Marc S. Raab, Marc-Andrea Baertsch, Maximilian Merz, MD
Source: oncodaily.comCategories: General Medicine News, Partners & KOLsTweet-
RT @oncodaily: Myeloma Paper of the Day, January 15th, suggested by @Myeloma_Doc https://t.co/FxHYl8nqPl #Cancer #Mmsm #MedEd #MedX #MedNā¦
-
-
Mashup Score: 0Cardiovascular Disease With Hormone Therapy and Ovarian Suppression in Premenopausal Breast Cancer Survivors: - 7 hour(s) ago
AbstractBackgroundHormone therapies, including aromatase inhibitors and tamoxifen, are used with ovarian suppression to improve outcomes in premenopausal patients with breast cancer. Cardiovascular…
Source: www.jacc.orgCategories: General Medicine News, Partners & KOLsTweet-
Premenopausal #BreastCA survivors treated with aromatase inhibitors & ovarian suppression face a 2.2-fold higher risk of #CVD compared to those on #tamoxifen. Regular #CVhealth monitoring is crucial. More: https://t.co/8CW5dWZHfd #JACCCardioOnc #BCsm #CardioOnc @ElizPolterā¦ https://t.co/u7neSsWPv8 https://t.co/TpE5TPg0i4
-
-
Mashup Score: 1Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma - 7 hour(s) ago
In a real-world cohort of relapsed/refractory multiple myeloma patients, bridging with bispecific T cellāengaging antibodies (BsAb) compares favorably to chemotherapy, anti-CD38, and anti-SLAMF7 antibody-based regimens for subsequent BCMA CAR-T cell therapy.
Source: aacrjournals.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @BCD_AACR: Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma https://t.co/lEjPPKwFq2ā¦
-
š° What are the clinical implications of the MARIPOSA trial meeting its OS endpoint? ā Don't miss this interview with @StephenVLiu of @Georgetown, @LombardiCancer, who joined us to share his insights. ā”ļø Watch now: https://t.co/9zsBgHGu9g #NSCLC #lcsm #EGFR https://t.co/F8lrYQ9YZl